Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA

Zhang, Zhikuan, Ohto, Umeharu, Shibata, Takuma, Krayukhina, Elena, Taoka, Masato, Yamauchi, Yoshio, Tanji, Hiromi, Isobe, Toshiaki +3 more·2016·Immunity
DOI 10.1016/j.immuni.2016.09.011

Cited by (476)

Items 101–200 of 476

  1. Sequence-Specific Sensing of Nucleic Acids
    Vabret, Nicolas, Bhardwaj, Nina, Greenbaum, Benjamin D. · 2017 · Trends in Immunology
  2. Structural evolution of toll-like receptor 7/8 agonists from imidazoquinolines to imidazoles
    Deepender Kaushik, Arshpreet Kaur, Nikolai Petrovsky, Deepak B. Salunke · 2021 · RSC Medicinal Chemistry
  3. Short single-stranded DNA degradation products augment the activation of Toll-like receptor 9
    Jelka Pohar, Duško Lainšček, Karolina Ivičak‐Kocjan, Miša Mojca Cajnko, Roman Jerala, Mojca Benčina · 2017 · Nature Communications
  4. Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8
    Peter G. Larson, Tamara A. Kucaba, Zhengming Xiong, Michael R. Olin, Thomas S. Griffith, David M. Ferguson · 2017 · ACS Medicinal Chemistry Letters
  5. Discrimination Between Self and Non-Self-Nucleic Acids by the Innate Immune System
    Takumi Kawasaki, Taro Kawai · 2018 · International review of cytology
  6. Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors
    Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, Nirmal Das, Dipika Sarkar · 2021 · Journal of Medicinal Chemistry
  7. Cyprinid‐specific duplicated membrane TLR5 senses dsRNA as functional homodimeric receptors
    Zhiwei Liao, Chunrong Yang, Rui Jiang, Wentao Zhu, Yong‐An Zhang, Jianguo Su · 2022 · EMBO Reports
  8. MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Thomas Wallach, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Molecular Neurodegeneration
  9. The association of COVID-19 severity and susceptibility and genetic risk factors: A systematic review of the literature
    Angela Ishak, Meghana Mehendale, Mousa M. AlRawashdeh, C. Sestacovschi, M. Sharath, Krunal Pandav, S. Marzban · 2022 · Gene
  10. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
    Albert Radikovich Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, Anna S. Rogova, Kirill Viktorovich Lepik, Vasiliy V. Reshetnikov, Roman A. Ivanov · 2023 · International Journal of Molecular Sciences
  11. The tRNA Val half: A strong endogenous Toll-like receptor 7 ligand with a 5′-terminal universal sequence signature
    Kamlesh Pawar, Takuya Kawamura, Yohei Kirino · 2024 · Proceedings of the National Academy of Sciences
  12. DNA-based fluorescent probes of NOS2 activity in live brains
    Aneesh Tazhe Veetil, Junyi Zou, Katharine W. Henderson, Maulik S. Jani, Shabana M. Shaik, Sangram S. Sisodia, Melina E. Hale, Yamuna Krishnan · 2020 · Proceedings of the National Academy of Sciences
  13. Toward a structural understanding of nucleic acid‐sensing Toll‐like receptors in the innate immune system
    Zhikuan Zhang, Umeharu Ohto, Toshiyuki Shimizu · 2017 · FEBS Letters
  14. Integrative Structural Biology of Protein-RNA Complexes
    Lyudmila Dimitrova-Paternoga, Pravin Kumar Ankush Jagtap, Po‐Chia Chen, Janosch Hennig · 2019 · Structure
  15. Targeting nuclear acid-mediated immunity in cancer immune checkpoint inhibitor therapies
    Miaoqin Chen, Shiman Hu, Yiling Li, Ting Jiang, Hongchuan Jin, Lifeng Feng · 2020 · Signal Transduction and Targeted Therapy
  16. The crosstalk between viral RNA- and DNA-sensing mechanisms
    Chunmei Cai, Yan‐Dong Tang, Guocai Xu, Chunfu Zheng · 2021 · Cellular and Molecular Life Sciences
  17. The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy
    Mingfeng Lee, Hitoshi Suzuki, Kei Ogiwara, Ryosuke Aoki, Rina Kato, Maiko Nakayama, Yusuke Fukao, Yoshihito Nihei, Toshiki Kano, Yuko Makita et al. · 2023 · Kidney International
  18. Shaping the Innate Immune Response Through Post-Transcriptional Regulation of Gene Expression Mediated by RNA-Binding Proteins
    Anissa Guillemin, Anuj Kumar, Mélanie Wencker, Emiliano P. Ricci · 2022 · Frontiers in Immunology
  19. Nucleic Acid Sensing by Toll-Like Receptors in the Endosomal Compartment
    Kensuke Miyake, Takuma Shibata, Ryutaro Fukui, Ryota Sato, Shin-ichiroh Saitoh, Yusuke Murakami · 2022 · Frontiers in Immunology
  20. Extracellular miR-146a-5p Induces Cardiac Innate Immune Response and Cardiomyocyte Dysfunction
    Briana K. Shimada, Yang Yang, Jing Zhu, Sheng Wang, Andrew O. Suen, Stephanie M. Kronstadt, Anjana Jeyaram, Steven M. Jay, Lin Zou, Wei Chao · 2020 · ImmunoHorizons
  21. Molecular mechanisms of nonself nucleic acid recognition by the innate immune system
    Carina C. de Oliveira Mann, Veit Hornung · 2021 · European Journal of Immunology
  22. Insights into innate immune activation via PS-ASO–protein–TLR9 interactions
    Adam J Pollak, Luyi Zhao, Timothy A. Vickers, Ian J. Huggins, Xue‐hai Liang, Stanley T. Crooke · 2022 · Nucleic Acids Research
  23. 50 Years of structural immunology
    Ian A. Wilson, Robyn L. Stanfield · 2021 · Journal of Biological Chemistry
  24. A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations
    In‐Hee Lee, Ji‐Won Lee, Sek Won Kong · 2020 · Infection Genetics and Evolution
  25. Therapeutic synthetic and natural materials for immunoengineering
    Anna Slezak, Kevin Chang, Samir Hossainy, Aslan Mansurov, Stuart J. Rowan, Jeffrey A. Hubbell, Mustafa Ozgur Guler · 2024 · Chemical Society Reviews
  26. Purine nucleoside phosphorylase enables dual metabolic checkpoints that prevent T cell immunodeficiency and TLR7-associated autoimmunity
    Evan R. Abt, Khalid Rashid, Thuc M. Le, Suwen Li, Hailey R. Lee, Vincent M. Lok, Luyi Li, Amanda L. Creech, Amanda N. Labora, Hanna K. Mandl et al. · 2022 · Journal of Clinical Investigation
  27. Harnessing host–virus evolution in antiviral therapy and immunotherapy
    Steven M. Heaton · 2019 · Clinical & Translational Immunology
  28. Toll-like receptors in innate immunity and inflammation: from fundamental biology to clinic insights
    Cheng Qian, Xuetao Cao, Jules A. Hoffmann · 2026 · Immunity & Inflammation
  29. Activation of innate immunity in primary human cells using a plant virus derived nanoparticle TLR7/8 agonist
    Damien Carignan, Sabine Herblot, Marie-Ève Laliberté-Gagné, Marilène Bolduc, Michel Duval, Pierre E. Savard, Denis Leclerc · 2017 · Nanomedicine Nanotechnology Biology and Medicine
  30. Long non-coding RNAs in antiviral immunity
    Tim Vierbuchen, Katherine A. Fitzgerald · 2020 · Seminars in Cell and Developmental Biology
  31. Identification and development of a novel 5-gene diagnostic model based on immune infiltration analysis of osteoarthritis
    Yaguang Han, Jun Wu, Zhenyu Gong, YiQin Zhou, HaoBo Li, Bo Wang, Qirong Qian · 2021 · Journal of Translational Medicine
  32. Innate sensors that regulate vaccine responses
    Philipp Georg, Leif Erik Sander · 2019 · Current Opinion in Immunology
  33. A novel miR1983-TLR7-IFNβ circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1
    Diana Shah, Andrea Comba, Syed Mohd Faisal, Padma Kadiyala, Gregory J. Baker, Mahmoud S. Alghamri, Robert Doherty, Daniel B. Zamler, Gabriel Núñez, Maria Graciela Castro et al. · 2021 · OncoImmunology
  34. Spatial Properties of Reactive Oxygen Species Govern Pathogen-Specific Immune System Responses
    Eunice E. To, John J. O’Leary, Luke A.J. O'Neill, Ross Vlahos, Steven Bozinovski, Christopher J. H. Porter, Robert D. Brooks, Doug A. Brooks, Stavros Selemidis · 2020 · Antioxidants and Redox Signaling
  35. Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells
    Claire Cénac, Mariette Ducatez, Jean‐Charles Guéry · 2021 · European Journal of Immunology
  36. Endosomal toll‐like receptors play a key role in activation of primary human monocytes by cowpea mosaic virus
    Marwah M. Albakri, Frank A. Veliz, Steven Fiering, Nicole F. Steinmetz, Scott F. Sieg · 2019 · Immunology
  37. Chemical Tools for Studying TLR Signaling Dynamics
    Timo Oosenbrug, Michel J. van de Graaff, Maaike E. Ressing, Sander I. van Kasteren · 2017 · Cell chemical biology
  38. RNA is taking its Toll: Impact of RNA‐specific Toll‐like receptors on health and disease
    Tim Vierbuchen, Karina Stein, Holger Heine · 2018 · Allergy
  39. Avian Toll-like receptor allelic diversity far exceeds human polymorphism: an insight from domestic chicken breeds
    Zuzana Świderská, A. Šmídová, Lucie Buchtová, Anna Bryjová, Anežka Fabiánová, Pavel Munclinger, Michal Vinkler · 2018 · Scientific Reports
  40. A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant Antagonist
    Ayan Mukherjee, Deblina Raychaudhuri, Bishnu Prasad Sinha, Biswajit Kundu, Mousumi Mitra, Barnali Paul, Purbita Bandopadhyay, Dipyaman Ganguly, Arindam Talukdar · 2020 · Journal of Medicinal Chemistry
  41. Toll-like receptor 7 deficiency suppresses type 1 diabetes development by modulating B-cell differentiation and function
    Juan Huang, Jian Peng, James Alexander Pearson, Georgios Efthimiou, Youjia Hu, Ningwen Tai, Yanpeng Xing, Luyao Zhang, Jianlei Gu, Jianping Jiang et al. · 2021 · Cellular and Molecular Immunology
  42. Influenza Viruses: Innate Immunity and mRNA Vaccines
    SangJoon Lee, Jin‐Hyeob Ryu · 2021 · Frontiers in Immunology
  43. Compositional biases in RNA viruses: Causes, consequences and applications
    Eleanor R. Gaunt, Paul Digard · 2021 · Wiley Interdisciplinary Reviews - RNA
  44. Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia
    Thomas E. Wallach, Martin Raden, Lukas Hinkelmann, Mariam Brehm, Dominik Rabsch, Hannah Weidling, Christina Krüger, Helmut Kettenmann, Rolf Backofen, Seija Lehnardt · 2023 · Frontiers in Immunology
  45. The architecture of transmembrane and cytoplasmic juxtamembrane regions of Toll-like receptors
    Fedor Kornilov, Alexandra V. Shabalkina, Cong Lin, Pavel E. Volynsky, Erik F. Kot, Alexey L. Kayushin, Владислав А. Лушпа, Marina V. Goncharuk, Alexander S. Arseniev, Sergey A. Goncharuk et al. · 2023 · Nature Communications
  46. Toll-like Receptor 7 Contributes to Inflammation, Organ Injury, and Mortality in Murine Sepsis
    Wenling Jian, Lili Gu, Brittney Williams, Yan Feng, Wei Chao, Lin Zou · 2019 · Anesthesiology
  47. Double methylation of tRNA-U54 to 2′-O-methylthymidine (Tm) synergistically decreases immune response by Toll-like receptor 7
    Patrick Keller, Isabel Freund, Virginie Marchand, Guillaume Bec, Raven Huang, Yuri Motorin, Tatjana Eigenbrod, Alexander H. Dalpke, Mark Helm · 2018 · Nucleic Acids Research
  48. Small molecule agonists of toll-like receptors 7 and 8: a patent review 2014 – 2020
    Madeleine E. Kieffer, Akash M. Patel, Scott A. Hollingsworth, W. Michael Seganish · 2020 · Expert Opinion on Therapeutic Patents
  49. What We Do Know and Do Not Yet Know about COVID-19 Vaccines as of the Beginning of the Year 2021
    Jin‐Hong Yoo · 2021 · Journal of Korean Medical Science
  50. Reprogramming of nucleotide metabolism by interferon confers dependence on the replication stress response pathway in pancreatic cancer cells
    Evan R. Abt, Thuc M. Le, Amanda M. Dann, Joseph R. Capri, Soumya Poddar, Vincent M. Lok, Luyi Li, Keke Liang, Amanda L. Creech, Khalid Rashid et al. · 2022 · Cell Reports
  51. Recent Advances on Small-Molecule Antagonists Targeting TLR7
    Haoyang Zheng, Peiyang Wu, Pierre‐Antoine Bonnet · 2023 · Molecules
  52. Computational Insight Into the Structural Organization of Full-Length Toll-Like Receptor 4 Dimer in a Model Phospholipid Bilayer
    Mahesh Chandra Patra, Hyuk‐Kwon Kwon, Maria Batool, Sangdun Choi · 2018 · Frontiers in Immunology
  53. Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics
    Xuan Huang, Xiao‐Yong Zhang, Mengji Lu · 2021 · Expert Opinion on Drug Discovery
  54. A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenza
    Julie C. F. Rappe, Katja Finsterbusch, Stefania Crotta, Matthias Mack, Simon Lawrence Priestnall, Andreas Wack · 2021 · The Journal of Experimental Medicine
  55. Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements
    Irina S. Balan, Laure Aurelian, Kimberly S. Williams, Brian Campbell, Rick B. Meeker, A. Leslie Morrow · 2022 · Frontiers in Immunology
  56. Cryo-electron Microscopic Analysis of Single-Pass Transmembrane Receptors
    Kai Cai, Xuewu Zhang, Xiao‐chen Bai · 2022 · Chemical Reviews
  57. Bruton's tyrosine kinase regulates TLR7/8-induced TNF transcription via nuclear factor-κB recruitment
    Theresa H. Page, Anna Urbaniak, Ana Isabel Espirito Santo, Lynett Danks, Timothy Smallie, Lynn M. Williams, Nicole J. Horwood · 2018 · Biochemical and Biophysical Research Communications
  58. Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
    Nasir Javaid, Farzana Yasmeen, Sangdun Choi · 2019 · Pharmaceutics
  59. When Innate Immunity Meets Angiogenesis—The Role of Toll-Like Receptors in Endothelial Cells and Pulmonary Hypertension
    Aneel Roy Bhagwani, Alfred A Roger Thompson, László Farkas · 2020 · Frontiers in Medicine
  60. Platelets and Immunity
    Milka Koupenova, Jane E. Freedman · 2020 · Arteriosclerosis Thrombosis and Vascular Biology
  61. Target-Based Identification and Optimization of 5‑Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay
    Thomas F. Knöpfel, Pierre Nimsgern, Sébastien Jacquier, Marjorie Bourrel, Eric Vangrevelinghe, Ralf Glatthar, Dirk Behnke, Phil B. Alper, Pierre‐Yves Michellys, Jonathan A. Deane et al. · 2020 · Journal of Medicinal Chemistry
  62. Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update
    George D. Kalliolias, Efthimia K. Basdra, Athanasios G. Papavassiliou · 2024 · Biomedicines
  63. Emerging evidence for endogenous neurosteroid modulation of pro-inflammatory and anti-inflammatory pathways that impact neuropsychiatric disease
    A. Leslie Morrow, Giorgia Boero, Irina S. Balan · 2024 · Neuroscience & Biobehavioral Reviews
  64. Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases
    Arunaksharan Narayanankutty · 2019 · Current Drug Targets
  65. Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9
    Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee, Bishnu Prasad Sinha, Dipika Sarkar, Purbita Bandopadhyay, Sourav Pal, Nirmal Das, Debdeep Dey, Kantubhukta Ramarao et al. · 2021 · Journal of Medicinal Chemistry
  66. A Single Dose of Anti-HBsAg Antibody-Encoding mRNA-LNPs Suppressed HBsAg Expression: a Potential Cure of Chronic Hepatitis B Virus Infection
    Binfan Chen, Yuchen Chen, Jian Li, Chunyu Wang, Wenping Song, Yumei Wen, Jinzhong Lin, Yanling Wu, Tianlei Ying · 2022 · mBio
  67. Latest Advances in Small Molecule TLR 7/8 Agonist Drug Research
    David C. McGowan · 2019 · Current Topics in Medicinal Chemistry
  68. Promotion of TLR7-MyD88-dependent inflammation and autoimmunity in mice through stem-loop changes in Lnc-Atg16l1
    Zongheng Yang, Shuchen Ji, Lun Liu, Shuo Liu, Bingjing Wang, Yuanwu Ma, Xuetao Cao · 2024 · Nature Communications
  69. A Novel Small-Molecule Inhibitor of Endosomal TLRs Reduces Inflammation and Alleviates Autoimmune Disease Symptoms in Murine Models
    Mahesh Chandra Patra, Asma Achek, Gi‐Young Kim, Suresh Panneerselvam, Hyeon‐Jun Shin, Wook-Yong Baek, Wang‐Hee Lee, June Sung, Uisuk Jeong, Eun-Young Cho et al. · 2020 · Cells
  70. Modulation of Toll-like receptor 1 intracellular domain structure and activity by Zn2+ ions
    Владислав А. Лушпа, Marina V. Goncharuk, Cong Lin, Arthur O. Zalevsky, Irina A. Talyzina, Aleksandra P. Luginina, Daniil D. Vakhrameev, Mikhail B. Shevtsov, Sergey A. Goncharuk, Alexander S. Arseniev et al. · 2021 · Communications Biology
  71. TLR7/8 stress response drives histiocytosis in SLC29A3 disorders
    Takuma Shibata, Ryota Sato, Masato Taoka, Shin-ichiroh Saitoh, Mayumi Komine, Kiyoshi Yamaguchi, Susumu Goyama, Yuji Motoi, Jiro Kitaura, Kumi Izawa et al. · 2023 · The Journal of Experimental Medicine
  72. Somatic gain-of-function mutation in TLR7 causes early-onset systemic lupus erythematosus
    Yi Zeng, Panfeng Tao, Jun Wang, Ting Li, Yue Du, Xiuli Wang, Wei Wang, Siming Peng, Wei Wang, Mingsheng Ma et al. · 2025 · Annals of the Rheumatic Diseases
  73. Identification of an optimized 2′-O-methylated trinucleotide RNA motif inhibiting Toll-like receptors 7 and 8
    Felix C. F. Schmitt, Isabel Freund, Markus A. Weigand, Mark Helm, Alexander H. Dalpke, Tatjana Eigenbrod · 2017 · RNA
  74. A novel Toll-like receptor 7/8–specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus
    Sally T. Ishizaka, Lynn D. Hawkins, Qian Chen, Fumitoshi Tago, Takuya Yagi, Kentaro Sakaniwa, Zhikuan Zhang, Toshiyuki Shimizu, Manabu Shirato · 2023 · European Journal of Pharmacology
  75. Small molecule modulators of immune pattern recognition receptors
    Taku Tsukidate, Charles W. Hespen, Howard C. Hang · 2023 · RSC Chemical Biology
  76. Persistent mycobacteria evade an antibacterial program mediated by phagolysosomal TLR7/8/MyD88 in human primary macrophages
    Alexandre Gidon, Signe Elisabeth Åsberg, Claire Louet, Liv Ryan, Markus Haug, Trude Helen Flo · 2017 · PLoS Pathogens
  77. Deoxyguanosine is a TLR7 agonist
    Tamara Davenne, Anne Bridgeman, Rachel E. Rigby, Jan Rehwinkel · 2019 · European Journal of Immunology
  78. Advancing mRNA technologies for therapies and vaccines: An African context
    Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
  79. NF-κB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasis
    Angela Rose Liu, Nandini Sarkar, Jordan D. Cress, Tristan J de Jesus, Ananya Vadlakonda, Joshua T Centore, Alexis D. Griffith, Bethany R. Rohr, Thomas S. McCormick, Kevin D. Cooper et al. · 2024 · EBioMedicine
  80. 2′-O-Methyl-guanosine RNA fragments antagonize TLR7 and TLR8 to limit autoimmunity
    Arwaf S. Alharbi, Sunil Sapkota, Zhikuan Zhang, Ruitao Jin, Erandi Rupasinghe, W. Samantha N. Jayasekara, Dingyi Yu, Mary Speir, Lorna E. Wilkinson‐White, Liza Cubeddu et al. · 2026 · Nature Immunology
  81. Emerging role of RNA sensors in tumor microenvironment and immunotherapy
    Rui Yun Yang, Sihui Yu, Tianhan Xu, Jiawen Zhang, Sufang Wu · 2022 · Journal of Hematology & Oncology
  82. Inborn Errors of Purine Salvage and Catabolism
    Marcella Camici, Mercedes Garcia‐Gil, S. Allegrini, Rossana Pesi, Giulia Bernardini, Vanna Micheli, Maria Grazia Tozzi · 2023 · Metabolites
  83. Identification and Optimization of Pyrrolo[3,2-d]pyrimidine Toll-like Receptor 7 (TLR7) Selective Agonists for the Treatment of Hepatitis B
    David C. McGowan, Florence Herschke, Frederik Pauwels, Bart Stoops, Ilham Smyej, Stefaan Last, Serge Pieters, Werner Embrechts, Mourad Daoubi Khamlichi, Tine Thoné et al. · 2017 · Journal of Medicinal Chemistry
  84. Targeting the innate immune receptor TLR8 using small-molecule agents
    Kentaro Sakaniwa, Toshiyuki Shimizu · 2020 · Acta Crystallographica Section D Structural Biology
  85. Mesenchymal Stem Cell-Derived Exosomes Attenuate TLR7-Mediated Mast Cell Activation
    Kyung‐Ah Cho, Je-Eun Cha, Jung-Woo Kim, Yu‐Hee Kim, Kyung‐Ha Ryu, So‐Youn Woo · 2021 · Tissue Engineering and Regenerative Medicine
  86. Autophagy and antiviral defense
    Po‐Yuan Ke · 2021 · IUBMB Life
  87. TLR7 neo-functionalizes to sense dsRNA and trigger antiviral and antibacterial immunity in non-tetrapod vertebrates
    Rui Jiang, Wentao Zhu, Zhiwei Liao, Chunrong Yang, Jianguo Su · 2023 · iScience
  88. Study on the Characterization and Degradation Pattern of Circular RNA Vaccines Using an HPLC Method
    Feiran Cheng, Ji Li, Chaoying Hu, Yu Bai, Jianyang Liu, Dong Liu, Qian He, Qiuheng Jin, Qunying Mao, Zhenglun Liang et al. · 2024 · Chemosensors
  89. Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling
    Ruth Shiloh, Ruth Lubin, Odeya David, Ifat Geron, Elimelech Okon, Idit Hazan, Marketa Kubricanova Zaliova, Gil Amarilyo, Yehudit Birger, Yael Borovitz et al. · 2023 · Blood
  90. Nucleotide modifications enable rational design of TLR7-selective ligands by blocking RNase cleavage
    Ann-Jay Tong, Rebecca A. Leylek, Anna‐Maria Herzner, Diamanda Rigas, Sara M. Wichner, Craig Blanchette, Siri Tähtinen, Christopher C. Kemball, Ira Mellman, Benjamin Haley et al. · 2023 · The Journal of Experimental Medicine
  91. COVID-19: The Effect of Host Genetic Variations on Host–Virus Interactions
    Suvobrata Chakravarty · 2020 · Journal of Proteome Research
  92. RNA recognition in toll-like receptor signaling
    Toshiyuki Shimizu · 2024 · Current Opinion in Structural Biology
  93. Structural basis for species‐specific activation of mouse Toll‐like receptor 9
    Hanako Ishida, Umeharu Ohto, Takuma Shibata, Kensuke Miyake, Toshiyuki Shimizu · 2018 · FEBS Letters
  94. Identification of U11snRNA as an endogenous agonist of TLR7-mediated immune pathogenesis
    Hideo Negishi, Nobuyasu Endo, Yuki Nakajima, Tatsuaki Nishiyama, Yuichiro Tabunoki, Junko Nishio, Ryuji Koshiba, Atsushi Matsuda, Kosuke Matsuki, Tomohisa Okamura et al. · 2019 · Proceedings of the National Academy of Sciences
  95. Host-pathogen protein-nucleic acid interactions: A comprehensive review
    Anuja Jain, Shikha Mittal, Lokesh P. Tripathi, Ruth Nussinov, Shandar Ahmad · 2022 · Computational and Structural Biotechnology Journal
  96. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach
    Abdul Manan, Rameez Hassan Pirzada, Muhammad Haseeb, Sangdun Choi · 2022 · International Journal of Molecular Sciences
  97. Co-imaging of RelA and c-Rel reveals features of NF-κB signaling for ligand discrimination
    Shah Md Toufiqur Rahman, Apeksha Singh, S. W. Lowe, Mohammad Aqdas, Kevin Jiang, Haripriya Vaidehi Narayanan, Alexander Hoffmann, Myong‐Hee Sung · 2024 · Cell Reports
  98. Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors 7 and 8
    Rosaura Padilla‐Salinas, Rachel Lynn Anderson, Kentaro Sakaniwa, Shuting Zhang, Patrick Nordeen, Chuan‐Jun Lu, Toshiyuki Shimizu, Hang Hubert Yin · 2019 · Journal of Medicinal Chemistry
  99. Switch-like compaction of poly(ADP-ribose) upon cation binding
    Mohsen Badiee, Adam L. Kenet, Laura R. Ganser, Tapas Paul, Sua Myong, Anthony K. L. Leung · 2023 · Proceedings of the National Academy of Sciences
  100. Innate Immune Response against Hepatitis C Virus: Targets for Vaccine Adjuvants
    Daniel Sepúlveda‐Crespo, Salvador Resino, Isidoro Martínez · 2020 · Vaccines